Blood Markers for Managing High Blood Pressure in Pregnancy
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This study looks at whether certain blood markers (called angiogenic factors) can help manage high blood pressure in pregnancy without having to deliver the baby early. If you have gestational hypertension, this trial may help doctors decide the best way to keep you and your baby healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 24 to 40 weeks pregnant.
- You have gestational hypertension (high blood pressure that started during pregnancy).
- You have had a blood test showing your sFlt-1/PIGF ratio is 33 or lower.
- You are pregnant with only one baby.
- You do not have certain health problems like kidney disease, heart disease, or a blood vessel condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny particles released from blood vessels in pregnant women with high blood pressure. The goal is to find better ways to detect and manage conditions like preeclampsia.
This study tests if certain blood markers can help diagnose and monitor preeclampsia. It aims to improve how this serious pregnancy condition is detected and treated.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study looks at how well your blood vessels work during pregnancy to help predict high blood pressure disorders. If you join, you will have extra monitoring and blood tests.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
Hear when a new Gestational Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.